Ikaros integrates endocrine and immune system development

Journal of Clinical Investigation

Volumn 115, Issue 4, 2005, Pages 1021-1029

  Ezzat, Shereen ^a,b   Mader, Rene ^b,c   Yu, ShunJiang ^a,b   Ning, Terry ^d   Poussier, Philippe ^d   Asa, Sylvia L ^b,c  

^a MOUNT SINAI HOSPITAL   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; DEXAMETHASONE; GLUCOCORTICOID; IKAROS TRANSCRIPTION FACTOR; PROOPIOMELANOCORTIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADRENAL GLUCOCORTICOID INSUFFICIENCY; ADRENAL INSUFFICIENCY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORTICOMELANOTROPH CELL; ENDOCRINE SYSTEM; FETUS; GENE EXPRESSION; HORMONE DEFICIENCY; HYPOPHYSIS CELL; IMMUNE SYSTEM; IMMUNOMODULATION; IN VIVO STUDY; LYMPHOPOIESIS; MOUSE; NONHUMAN; ORGANOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SURVIVAL;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; BASE SEQUENCE; BINDING SITES; CARRIER PROTEINS; CELLS, CULTURED; DNA-BINDING PROTEINS; ENDOCRINE SYSTEM; GENE EXPRESSION REGULATION; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IKAROS TRANSCRIPTION FACTOR; IMMUNE SYSTEM; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; PITUITARY GLAND; PITUITARY-ADRENAL SYSTEM; PRO-OPIOMELANOCORTIN; PROMOTER REGIONS (GENETICS); SURVIVAL RATE; TRANSCRIPTION FACTORS;

EID: 16844373321     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200522486     Document Type: Article

References (36)

1. Chrousos, G.P. 1995. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N. Engl. J. Med. 332:1351-1362.
2. Turnbull, A.V., and Rivier, C.L. 1999. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol. Rev. 79:1-71.
3. Asa, S.L., and Ezzat, S. 1998. The cytogenesis and pathogenesis of pituitary adenomas. Endocr. Rev. 19:798-827.
4. Asa, S.L., and Ezzat, S. 1999. Molecular determinants of pituitary cytodifferentiation. Pituitary. 1:159-168.
5. Molnar, A., et al. 1996. The Ikaros gene encodes a family of lymphocyte-restricted zinc finger DNA binding proteins, highly conserved in human and mouse. J. Immunol. 156:585-592.
6. Georgopoulos, K., Winandy, S., and Avitahl, N. 1997. The role of the Ikaros gene in lymphocyte development and homeostasis. Annu. Rev. Immunol. 15:155-176.
7. Yu, S., Asa, S.L., and Ezzat, S. 2002. Fibroblast growth factor receptor 4 is a target for the zinc-finger transcription factor Ikaros in the pituitary. Mol. Endocrinol. 16:1069-1078.
8. Armstrong, E., Partanen, J., Cannizzaro, L., Huebner, K., and Alitalo, K. 1992. Localization of the fibroblast growth factor receptor-4 gene to chromosome region 5q33-qter. Genes Chromosomes Cancer. 4:94-98.
9. Ezzat, S., Yu, S., and Asa, S.L. 2003. Ikaros isoforms in human pituitary tumors: distinct localization, histone acetylation, and activation of the 5′ fibroblast growth factor receptor-4 promoter. Am. J. Pathol. 163:1177-1184.
10. Yu, S., Asa, S.L., Weigel, R.J., and Ezzat, S. 2003. Pituitary tumor AP-2alpha recognizes a cryptic promoter in intron 4 of fibroblast growth factor receptor 4. J. Biol. Chem. 278:19597-19602.
11. Pulichino, A.M., et al. 2003. Human and mouse TPIT gene mutations cause early onset pituitary ACTH deficiency. Genes Dev. 17:711-716.
12. Cortes, M., Wong, E., Koipally, J., and Georgopoulos, K. 1999. Control of lymphocyte development by the Ikaros gene family. Curr. Opin. Immunol. 11:167-171.
13. Wang, J.H., et al. 1996. Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity. 5:537-549.
14. Winandy, S., Wu, L., Wang, J.H., and Georgopoulos, K. 1999. Pre-T cell receptor (TCR) and TCR-controlled checkpoints in T cell differentiation are set by Ikaros. J. Exp. Med. 190:1039-1048.
15. Winandy, S., Wu, P., and Georgopoulos, K. 1995. A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma. Cell. 83:289-299.
16. Avitahl, N., et al. 1999. Ikaros sets thresholds for T cell activation and regulates chromosome propagation. Immunity. 10:333-343.
17. Abbass, S.A.A., Asa, S.L., and Ezzat, S. 1997. Altered expression of fibroblast growth factor receptors in human pituitary adenomas. J. Clin. Endocrinol. Metab. 82:1160-1166.
18. Weinstein, M., Xu, X., Ohyama, K., and Deng, C.X. 1998. FGFR-3 and FGFR-4 function cooperatively to direct alveogenesis in the murine lung. Development. 125:3615-3623.
19. Lamolet, B., et al. 2001. A pituitary cell-restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins. Cell. 104:849-859.
20. Maira, M., et al. 2003. The T-box factor Tpit recruits SRC/p 160 co-activators and mediates hormone action. J. Biol. Chem. 278:46523-46532.
21. Molnar, A., and Georgopoulos, K. 1994. The Ikaros gene encodes a family of functionally diverse zinc finger DNA-binding proteins. Mol. Cell. Biol. 14:8292-8303.
22. Sun, L., Liu, A., and Georgopoulos, K. 1996. Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development. EMBO J. 15:5358-5369.
23. Koipally, J., Renold, A., Kim, J., and Georgopoulos, K. 1999. Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes. EMBO J. 18:3090-3100.
24. Wargnier, A., et al. 1998. Down-regulation of human granzyme B expression by glucocorticoids. Dexamethasone inhibits binding to the Ikaros and AP-1 regulatory elements of the granzyme B promoter. J. Biol. Chem. 273:35326-35331.
25. Kim, J., et al. 1999. Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. Immunity. 10:345-355.
26. Perdomo, J., Holmes, M., Chong, B., and Crossley, M. 2000. Eos and pegasus, two members of the ikaros family of proteins with distinct DNA binding activities J. Biol. Chem. 275:38347-38354.
27. Koipally, J., and Georgopoulos, K. 2002. Ikaros-CtIP interactions do not require C-terminal binding protein and participate in a deacetylase-independent mode of repression. J. Biol. Chem. 277:23143-23149.
28. Jacks, T., et al. 1992. Effects of an Rb mutation in the mouse. Nature. 359:295-300.
29. Asa, S.L., and Ezzat, S. 2002. The pathogenesis of pituitary tumours. Nat. Rev. Cancer. 2:836-849.
30. Sabbattini, P., et al. 2001. Binding of Ikaros to the lambda5 promoter silences transcription through a mechanism that does not require heterochromatin formation. EMBO J. 20:2812-2822.
31. Georgopoulos, K. 2002. Haematopoietic cell-fate decisions, chromatin regulation and ikaros. Nat. Rev. Immunol. 2:162-174.
32. Bennani-Bäiti, I.M., et al. 1998. DNase I-hypersensitive sites I and II of the human growth hormone locus control region are a major developmental activator of somatotrope gene expression. Proc. Natl. Acad. Sci. U. S. A. 95:10655-10660.
33. Shewchuk, B.M., Asa, S.L., Cooke, N.E., and Liebhaber, S.A. 1999. Pit-1 binding sites at the somatotrope-specific DNase I hypersensitive sites I, II of the human growth hormone locus control region are essential for in vivo hGH-N gene activation. J. Biol. Chem. 274:35725-35733.
34. Asa, S.L., Coschigano, K.T., Bellush, L., Kopchick, J.J., and Ezzat, S. 2000. Evidence for growth hormone (GH) autoregulation in pituitary somatotrophs in GH antagonist-transgenic mice and GH receptor-deficient mice. Am. J. Pathol. 156:1009-1015.
35. Nichogiannopoulou, A., Trevisan, M., Neben, S., Friedrich, C., and Georgopoulos, K. 1999. Defects in hemopoietic stem cell activity in Ikaros mutant mice. J. Exp. Med. 190:1201-1214.
36. Poussier, P., Ning, T., Banerjee, D., and Julius, M. 2002. A unique subset of self-specific intraintestinal T cells maintains gut integrity. J. Exp. Med. 195:1491-1497.